BiotechTube
Home/TauC3 Biologics/Scott Pollack, PhD
SP

Scott Pollack, PhD

Scientific Leader (implied)

TauC3 Biologics

Therapeutic Areas

Neurodegenerative DiseasesFrontotemporal DementiaProgressive Supranuclear Palsy

TauC3 Biologics Pipeline

DrugIndicationPhase
Undisclosed Tau ImmunotherapyTau-related Frontotemporal Dementia (FTD-tau)Pre-clinical

Leadership Team at TauC3 Biologics

BG
Bia Goncalves, PhD
Director of Scientific Communications
PM
Peter McGowan
Chief Financial Officer
MP
Michael P. Ross, PhD, CFA
Board Member
SV
Shafique Virani, MD
Director
PS
Parag Saxena
Director
JS
John S. Gogol
Director
RA
Richard A. Margolin, MD
Director
DG
Daniel G. Chain, PhD
Director/Scientific Founder
View full TauC3 Biologics profile